vs
Orthofix Medical Inc.（OFIX）与PAR TECHNOLOGY CORP（PAR）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是PAR TECHNOLOGY CORP的1.8倍（$219.9M vs $120.1M），PAR TECHNOLOGY CORP同比增速更快（14.4% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-12.5M），过去两年PAR TECHNOLOGY CORP的营收复合增速更高（30.9% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
PAR科技公司是全球领先的销售点系统、餐饮酒店管理软件及集成技术解决方案提供商，核心业务覆盖餐饮服务、酒店文旅及政府安防领域，为各类规模客户提供云端工具以简化运营、提升消费体验与经营效率。
OFIX vs PAR — 直观对比
营收规模更大
OFIX
是对方的1.8倍
$120.1M
营收增速更快
PAR
高出12.4%
2.0%
自由现金流更多
OFIX
多$29.4M
$-12.5M
两年增速更快
PAR
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $120.1M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | 41.2% |
| 营业利润率 | 0.2% | -15.0% |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | 14.4% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $-0.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPAR
| Q4 25 | $219.9M | $120.1M | ||
| Q3 25 | $205.6M | $119.2M | ||
| Q2 25 | $203.1M | $112.4M | ||
| Q1 25 | $193.6M | $103.9M | ||
| Q4 24 | $215.7M | $105.0M | ||
| Q3 24 | $196.6M | $96.8M | ||
| Q2 24 | $198.6M | $78.2M | ||
| Q1 24 | $188.6M | $70.1M |
净利润OFIXPAR
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-18.2M | ||
| Q2 25 | $-14.1M | $-21.0M | ||
| Q1 25 | $-53.1M | $-24.4M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $-19.8M | ||
| Q2 24 | $-33.4M | $54.2M | ||
| Q1 24 | $-36.0M | $-18.3M |
毛利率OFIXPAR
| Q4 25 | 71.1% | 41.2% | ||
| Q3 25 | 72.2% | 41.3% | ||
| Q2 25 | 68.7% | 45.4% | ||
| Q1 25 | 62.8% | 46.5% | ||
| Q4 24 | 69.0% | 42.9% | ||
| Q3 24 | 68.7% | 44.5% | ||
| Q2 24 | 67.8% | 41.0% | ||
| Q1 24 | 67.5% | 37.2% |
营业利润率OFIXPAR
| Q4 25 | 0.2% | -15.0% | ||
| Q3 25 | -8.3% | -14.8% | ||
| Q2 25 | -7.9% | -15.4% | ||
| Q1 25 | -25.2% | -15.2% | ||
| Q4 24 | -5.3% | -15.6% | ||
| Q3 24 | -9.6% | -15.7% | ||
| Q2 24 | -12.5% | -26.5% | ||
| Q1 24 | -15.6% | -38.2% |
净利率OFIXPAR
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -15.3% | ||
| Q2 25 | -6.9% | -18.7% | ||
| Q1 25 | -27.4% | -23.4% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | -20.5% | ||
| Q2 24 | -16.8% | 69.3% | ||
| Q1 24 | -19.1% | -26.1% |
每股收益（稀释后）OFIXPAR
| Q4 25 | $-0.05 | $-0.52 | ||
| Q3 25 | $-0.57 | $-0.45 | ||
| Q2 25 | $-0.36 | $-0.52 | ||
| Q1 25 | $-1.35 | $-0.60 | ||
| Q4 24 | $-0.76 | $-0.56 | ||
| Q3 24 | $-0.71 | $-0.56 | ||
| Q2 24 | $-0.88 | $1.60 | ||
| Q1 24 | $-0.95 | $-0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $80.1M |
| 总债务越低越好 | — | $394.0M |
| 股东权益账面价值 | $450.0M | $825.1M |
| 总资产 | $850.6M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.48× |
8季度趋势，按日历期对齐
现金及短期投资OFIXPAR
| Q4 25 | $82.0M | $80.1M | ||
| Q3 25 | $62.9M | $93.0M | ||
| Q2 25 | $65.6M | $85.7M | ||
| Q1 25 | $58.0M | $92.2M | ||
| Q4 24 | $83.2M | $108.6M | ||
| Q3 24 | $30.1M | $118.4M | ||
| Q2 24 | $26.4M | $142.5M | ||
| Q1 24 | $27.0M | $72.5M |
总债务OFIXPAR
| Q4 25 | — | $394.0M | ||
| Q3 25 | $157.2M | $393.4M | ||
| Q2 25 | $157.0M | $392.8M | ||
| Q1 25 | $156.9M | $392.3M | ||
| Q4 24 | $157.0M | $368.4M | ||
| Q3 24 | $118.5M | $466.7M | ||
| Q2 24 | $118.0M | $378.7M | ||
| Q1 24 | $118.2M | $378.2M |
股东权益OFIXPAR
| Q4 25 | $450.0M | $825.1M | ||
| Q3 25 | $442.5M | $838.0M | ||
| Q2 25 | $458.3M | $859.1M | ||
| Q1 25 | $458.3M | $852.0M | ||
| Q4 24 | $503.1M | $871.7M | ||
| Q3 24 | $525.9M | $692.7M | ||
| Q2 24 | $546.0M | $588.3M | ||
| Q1 24 | $570.3M | $526.4M |
总资产OFIXPAR
| Q4 25 | $850.6M | $1.4B | ||
| Q3 25 | $832.6M | $1.4B | ||
| Q2 25 | $837.2M | $1.4B | ||
| Q1 25 | $823.1M | $1.4B | ||
| Q4 24 | $893.3M | $1.4B | ||
| Q3 24 | $867.9M | $1.3B | ||
| Q2 24 | $882.0M | $1.1B | ||
| Q1 24 | $906.0M | $1.0B |
负债/权益比OFIXPAR
| Q4 25 | — | 0.48× | ||
| Q3 25 | 0.36× | 0.47× | ||
| Q2 25 | 0.34× | 0.46× | ||
| Q1 25 | 0.34× | 0.46× | ||
| Q4 24 | 0.31× | 0.42× | ||
| Q3 24 | 0.23× | 0.67× | ||
| Q2 24 | 0.22× | 0.64× | ||
| Q1 24 | 0.21× | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-11.8M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-12.5M |
| 自由现金流率自由现金流/营收 | 7.6% | -10.4% |
| 资本支出强度资本支出/营收 | 4.9% | 0.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-30.5M |
8季度趋势，按日历期对齐
经营现金流OFIXPAR
| Q4 25 | $27.7M | $-11.8M | ||
| Q3 25 | $12.4M | $8.4M | ||
| Q2 25 | $11.6M | $-6.6M | ||
| Q1 25 | $-18.4M | $-17.2M | ||
| Q4 24 | $23.7M | $3.4M | ||
| Q3 24 | $11.7M | $8.8M | ||
| Q2 24 | $9.0M | $-13.8M | ||
| Q1 24 | $-18.6M | $-23.6M |
自由现金流OFIXPAR
| Q4 25 | $16.8M | $-12.5M | ||
| Q3 25 | $2.5M | $7.0M | ||
| Q2 25 | $4.5M | $-7.4M | ||
| Q1 25 | $-25.1M | $-17.6M | ||
| Q4 24 | $15.2M | $3.2M | ||
| Q3 24 | $6.3M | $8.4M | ||
| Q2 24 | $-360.0K | $-14.2M | ||
| Q1 24 | $-29.1M | $-23.6M |
自由现金流率OFIXPAR
| Q4 25 | 7.6% | -10.4% | ||
| Q3 25 | 1.2% | 5.9% | ||
| Q2 25 | 2.2% | -6.6% | ||
| Q1 25 | -13.0% | -16.9% | ||
| Q4 24 | 7.0% | 3.0% | ||
| Q3 24 | 3.2% | 8.7% | ||
| Q2 24 | -0.2% | -18.2% | ||
| Q1 24 | -15.4% | -33.7% |
资本支出强度OFIXPAR
| Q4 25 | 4.9% | 0.7% | ||
| Q3 25 | 4.8% | 1.1% | ||
| Q2 25 | 3.5% | 0.7% | ||
| Q1 25 | 3.5% | 0.4% | ||
| Q4 24 | 4.0% | 0.2% | ||
| Q3 24 | 2.7% | 0.4% | ||
| Q2 24 | 4.7% | 0.5% | ||
| Q1 24 | 5.6% | 0.1% |
现金转化率OFIXPAR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.26× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PAR
| Subscription Service | $76.1M | 63% |
| Hardware | $27.8M | 23% |
| Professional Service | $16.2M | 13% |
